Saturday, September 23, 2023
Saturday, September 23, 2023

SAFEZONE Celebrates 13th Anniversary & Big Wins

SAFEZONE is celebrating its 13th anniversary and some of its big wins in healthcare solutions, including the latest in overcoming COVID.

Having commemorated 13 WONDERFULL, SUCCESSFULL years in business, SAFEZONE, Inc. now reaches a milestone for the VIRGINIA-based HEALTHCARE SOLUTIONS business, providing HEALTHCARE SOLUTIONS to COVID, fitness for the elderly, instructions for schools, educational institutions, corporations, and government agencies since 2007.

SAFEZONE, Inc. got its start in 2007 when founder Krishna Grandhi, one of the family members passed away because of Early COVID days and that made its CEO invent the company’s pandemic contact tracing solution with authentic health vitals.

One of the earliest challenges SAFEZONE faced was developing the technology of contact tracing with authentic information on health vitals when there were no other devices with temperature and oximeter readings in 2019.

Only SafeZone, Inc. customized the sensors in accordance with the demand for them.

While every business must face challenges, some like SAFEZONE are fortunate to enjoy truly successful wins and victories over these 13 blessed years.

Victory came when SAFEZONE was first to implement its Covid solution on Carnival Cruise Liners to protect and prevent passengers before they boarded the ships and also protecting students and teachers at many universities, UONV and schools in various states in the country.

Today dozens of Corporations use SAFEZONE device to stop the spread of the virus even after vaccinations, knowing prevention is better than consequence, so they’re also using the device to contact trace their employees in case of virus symptoms detection.

Brain F, VP of Sales at SAFEZONE, Inc. was also quoted when discussing another big win. “One of the high points of SAFEZONE’s history so far was moving into full health care solution via continuous monitoring of EKG and Blood Sugar using our FDA approved platform.”

SAFEZONE Inc’s Founder, Krishna Grandhi says, “We’re delighted to be celebrating our 13 Year Anniversary. I believe the secret to getting this far in business today is unique solution that doesn’t exist anywhere in the world.”

SAFEZONE Inc currently consists of 30 employees and has big plans for the upcoming year. One of its core objectives is to Help Communities with innovative solutions that do not exist in the world.

SAFEZONE thanks their friends, customers and all its partners for their well wishes on this happy occasion.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy